The conceptual category of ZFP963 Inhibitors encompasses a diverse array of chemical compounds designed to indirectly modulate the activity or expression of ZFP963 through the alteration of various signaling pathways and cellular processes. Given ZFP963's presumed role as a zinc finger protein involved in transcriptional regulation, the selected inhibitors target mechanisms such as DNA methylation, histone acetylation, and chromatin remodeling. These processes are crucial for the regulation of gene expression and are pathways through which ZFP963 is likely to exert its biological effects.
This approach to identifying potential inhibitors underscores the complexity of transcriptional regulation and the interconnected nature of cellular signaling networks. By targeting key regulatory processes that influence gene expression, such as chromatin accessibility and the activity of transcription factors, these inhibitors offer insights into the biological functions of ZFP963 and its role in cellular processes. Through such exploration, the selected compounds not only facilitate a deeper understanding of ZFP963's involvement in gene expression but also underscore the broader principles of cellular regulation and signal transduction. This methodology exemplifies the potential of targeted chemical intervention to modulate the function of specific proteins indirectly, providing a foundation for further research into the mechanisms of transcriptional regulation and the role of zinc finger proteins like ZFP963 in these processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Inhibits DNA methyltransferase, potentially altering DNA methylation and impacting ZFP963-regulated gene expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC inhibitor, could modify chromatin structure, potentially influencing ZFP963's role in transcription. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
Selective HDAC inhibitor, potentially affects chromatin accessibility and ZFP963 activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $196.00 | 9 | |
Broad-spectrum HDAC inhibitor, might influence ZFP963's role in transcriptional regulation. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
DNA methyltransferase inhibitor, could affect methylation patterns of genes regulated by ZFP963. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor, potentially affecting chromatin state and gene expression regulated by ZFP963. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
BET bromodomain inhibitor, could disrupt protein-protein interactions affecting ZFP963 function. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
BET bromodomain inhibitor, might influence ZFP963-mediated gene regulation. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $90.00 $238.00 $300.00 | ||
EZH2 methyltransferase inhibitor, potentially affecting histone methylation and ZFP963 regulatory functions. | ||||||
LY3214996 | 1951483-29-6 | sc-507299 | 5 mg | $260.00 | ||
ERK1/2 inhibitor, potentially impacts signaling pathways that ZFP963 may be involved in. | ||||||